NCT00051285View on ClinicalTrials.gov

"ESSENTIAL-The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

PHASE3TerminatedINTERVENTIONAL

Enrollment

1,800

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Heart Failure, Congestive

Interventions

DRUG

Enoximone

Participants receive oral enoximone

DRUG

Enoximone placebo

Participants receive placebo to match enoximone

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY